Procurement Summary
Country: Brazil
Summary: Acquisition of Medicine to Comply with a Court Order.
Deadline: 08 Jan 2026
Posting Date: 22 Dec 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 132516048
Document Ref. No.: 90136/2025
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Medicine to comply with a Court Order. UASG code: 90116 Notice from: 12/22/2025 from 9:00 am to 12:30 pm and from 1:30 pm to 5:00 pm Proposal Delivery: from 12/22/2025 at 09:00 BRIMONIDINE TARTARATE, DOSAGE 2 MG/ML, PRESENTATION EYE DROPS Quantity: 3 CARBAMAZEPINE, DOSAGE 200 MG Quantity: 810 SILDENAFILA, CITRATE SALT COMPOSITION, CONCENTRATION 50 MG Quantity: 810 DICLOFENAC, COMPOSITION DIETHYLAMONIUM SALT, CONCENTRATION 20 MG/G, FORM PHARMACEUTICAL GEL Quantity: 6 SODIUM DIVALPROATE, CONCENTRATION 250 MG, PHARMACEUTICAL FORM PROLONGED RELEASE Quantity: 360 DIVALPROATE SODIUM, CONCENTRATION 500 MG, PHARMACEUTICAL FORM PROLONGED RELEASE Quantity: 1680 DORZOLAMIDE HYCLORHYDRATE, PRESENTATION ASSOCIATED WITH TIMOLOL, DOSAGE 2% + 0.5%, MEDICATION TYPE OPHTHALMIC SOLUTION Quantity: 8 OLMESARTAN MEDOXOMIL, COMPOSITION ASSOCIATED WITH HYDROCHLOROTHIAZIDE, CONCENTRATION 40 MG + 12.5 MG Quantity: 120 TELMISARTAN, ASSOCIATED ACTIVE PRINCIPLE WITH HYDROCHLOROTHIAZIDE, DOSAGE 80MG + 12.5MG Quantity: 120 VALSARTAN, COMPOSITION ASSOCIATED WITH HYDROCHLOROTHIAZIDE, CONCENTRATION 320 MG + 12.5 MG Quantity: 120 INSULIN, ASPART ORIGIN, CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL FEATURE WITH APPLICATOR Quantity: 10 INSULIN, ASPART TYPE, COMPOSITION WITH NICOTINAMIDE (VIT B3), CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 174 INSULIN, ASPART TYPE, COMPOSITION WITH NICOTINAMIDE (VIT B3), CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONS WITH APPLICATION SYSTEM Quantity: 25 LAMOTRIGINE, DOSAGE 50 MG Quantity: 180 LEVETIRACETAM, CONCENTRATION 250 MG Quantity: 1080 LEVETIRACETAM, CONCENTRATION 750 MG Quantity: 600 OLOPATADINE HYCLORHYDRATE, CONCENTRATION 1 MG/ML, PHARMACEUTICAL FORM ONLY...
Documents
Tender Notice